The clinical-stage biotech company is based in Sacramento, and is putting its drug candidate through medical trials.

AdvaMed, the MedTech Association, released its AI Policy Roadmap (the Roadmap) outlining policy priorities for Congress and the U.S. Food and Drug Administration (FDA).